NEU neuren pharmaceuticals limited

Ann: 2023 Annual Report to shareholders, page-48

  1. 1,476 Posts.
    lightbulb Created with Sketch. 373
    Yes thats also how I read it.

    anyone here who thinks they will have a say on takeover pricing or decision making is delusional, IMO.

    That decision will be - as @LittleT has alluded to - made by a combination of the NEU executives and board and enough of the top shareholders whom will vote in unity once an offer is made (that they accept as reasonable).

    Yes anyone else can buy and sell when they like - as mentioned its your choice - but none of us (well, except maybe @LittleT) will be influencing any takeover decisions or pricing.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.98
Change
0.130(1.01%)
Mkt cap ! $1.598B
Open High Low Value Volume
$13.15 $13.15 $12.92 $490.1K 37.39K

Buyers (Bids)

No. Vol. Price($)
1 11 $12.96
 

Sellers (Offers)

Price($) Vol. No.
$12.98 672 3
View Market Depth
Last trade - 10.10am 18/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.